Erythrocyte adenosine deaminase (ADA) activity was measured in 19 newly-diagnosed and 20 hyposensitized asthmatic children, as well as 11 age-matched normal children. ADA activity was determined by adenosine catalyzed reactions. The results showed:1) The mean value of ADA activity was 72.9±30.4μmole/min/unit OD54lnm in newly- diagnosed asthmatics; 52.7±37.9μmole/min/unit OD541nm in hyposensitized patients and 39.5±26.7μmole/min/unit OD54lnm in normal controls; 2) there was significant elevation in erythrocyte ADA activity in newly-diagnosed asthmatic patients as compared to normal controls (P<0.05), but there was no difference between newly-diagnosed and hyposensitized patients (P>0.05), and between hyposensitized patients and normal controls (P>0.2). The mechanism and possible clinical implication of increasing erythrocyte ADA activity in newly-diagnosed asthmatic patients are discussed.
Erythrocyte adenosine deaminase (ADA) activity was measured in 19 newly-diagnosed and 20 hyposensitized asthmatic children, as well as 11 age-matched normal children. ADA activity was determined by adenosine catalyzed reactions. The results showed:1) The mean value of ADA activity was 72.9±30.4μmole/min/unit OD54lnm in newly- diagnosed asthmatics; 52.7±37.9μmole/min/unit OD541nm in hyposensitized patients and 39.5±26.7μmole/min/unit OD54lnm in normal controls; 2) there was significant elevation in erythrocyte ADA activity in newly-diagnosed asthmatic patients as compared to normal controls (P<0.05), but there was no difference between newly-diagnosed and hyposensitized patients (P>0.05), and between hyposensitized patients and normal controls (P>0.2). The mechanism and possible clinical implication of increasing erythrocyte ADA activity in newly-diagnosed asthmatic patients are discussed.